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Introduction 
The ability to identify sites of post-translational modification in proteins is 
central to understanding the molecular details of pathways regulating their 
activity. Through recent advances in mass spectrometry, many of the 
phosphorylation sites in the human proteome have been experimentally 
determined, and the kinases responsible predicted according to well-
established consensus sequence motifs. However, what of other post-
translational modifications? Can we predict these with as much certainty as 
we can phosphorylation? Although the palmitoyl proteomes of many different 
tissues have been determined,1 reliable palmitoylation site prediction has thus 
far eluded us. 
 
Palmitoylation of NCX1 
The ubiquitous sodium / calcium exchanger NCX1 mediates transmembrane 
calcium transport controlled by the sodium gradient and membrane potential 
in numerous tissues. In cardiac muscle calcium efflux via NCX1 controls 
diastolic function,2 but abnormal NCX1 function contributes to cardiac 
arrhythmias and ischemia-reperfusion injury.3 In the absence of PIP2, NCX1 
inactivates when its autoinhibitory XIP domain (located at the N-terminal end 
of its large regulatory intracellular loop situated between transmembrane 
domains 5 and 6) interacts with a distal region of the same loop. NCX1 is 
palmitoylated at a single cysteine in this regulatory loop: unpalmitoylated 
exchangers are resistant to inactivation and retain substantial activity when 
wild type exchangers inactivate4, 5. 
There are multiple cysteines in the NCX1 regulatory loop but only cysteine 
739, located at the C terminal end of this loop close to transmembrane 
domain 6, becomes palmitoylated. In our recent paper6 we asked why this 
particular cysteine gets palmitoylated when neighbouring ones do not. A 
fusion protein between the NCX1 regulatory loop and YFP is palmitoylated at 
C7394, unequivocally demonstrating that the exchanger’s transmembrane 
domains are dispensable for palmitoylation. The ‘instructions’ to palmitoylate 
NCX1 must therefore lie within the regulatory loop.  
Alanine scanning mutagenesis around C739 was almost entirely without effect 
on NCX1 palmitoylation. Indeed, one of the only point mutations we could 
identify as having an effect on NCX1 palmitoylation was the rare human 
polymorphism S738F, which enhanced NCX1 palmitoylation, possibly by 
impeding its depalmitoylation. In contrast, deletion of a small ~20 amino acid 
region at the very C terminal end of the regulatory loop completely abrogated 
NCX1 palmitoylation. The secondary structure predictor Jpred strongly 
suggests that this region forms an -helix which is largely hydrophobic, with a 
small hydrophilic face (Figure 1). We hypothesised that membrane 
association of the hydrophobic side of this helix and / or the amino acids on its 
hydrophilic face may be important for NCX1 palmitoylation. Breaking the helix 
with prolines, introducing negative charges to its hydrophobic face, or alanine 
mutagenesis of the hydrophilic face all impaired NCX1 palmitoylation, 
whereas alanine mutagenesis on the helix’s hydrophobic face was without 
effect. The distance between the helix and C739 was not crucial: inserting 
alanine between the two did not impair NCX1 palmitoylation. When C739 and 
the amphipathic helix were added to the C terminus of YFP, the fusion protein 
became palmitoylated and, as a consequence, membrane localised. Our data 
are therefore consistent with a model in which the hydrophobic face of the 
amphipathic helix interacts with the membrane, while the hydrophilic face is 
exposed to the cytosol where it engages with the cellular palmitoylation 
machinery, with enzyme selectivity dictated by the requirement for specific 
residues at particular positions on the hydrophilic face of the helix. 
 
Substrate recognition by palmitoylating enzymes 
So what does this tell us concerning NCX1 palmitoylation and more generally 
about the palmitoylation of ion transporters and integral membrane proteins 
by DHHC-PATs? The hydrophobic face of the recognition helix will be readily 
accommodated within the lipid bilayer, positioning C739 close to the 
membrane for palmitoylation (Figure 1). Notably though, despite its 
hydrophobicity the helix alone is not sufficient to act as a membrane anchor, 
as an unpalmitoylatable (C739A) YFP-NCX1 intracellular loop fusion protein is 
freely distributed in the cytosol4. By interacting with negatively charged 
phospholipid head groups, polybasic domains may also position cysteines 
adjacent to membranes facilitating their palmitoylation7. As for the hydrophilic 
face of the helix, D741, H745, T748 but not K752 all play a role in the 
recognition of NCX1 by its palmitoylating enzyme, with H745 being the most 
important residue. A protein-protein interaction between this hydrophilic face 
and the palmitoylating enzyme probably precedes NCX1 palmitoylation.  
This relationship is notably different from that between the Na pump regulator 
phospholemman and its palmitoylating enzyme DHHC5, in which a disordered 
domain interaction between the intracellular regions of these proteins 
precedes palmitoylation8. This highlights the difficulties of predicting 
palmitoylation sites in proteins: the recognition rules that apply to one DHHC-
PAT may apply to closely related family members, but not to all enzymes. 
From a therapeutic point of view this is good news, because it means we 
should be able to specifically target individual DHHC-PATs, or even individual 
substrates, but there is still a long way to go before palmitoylation sites can be 
accurately predicted. Once we have identified the DHHC-PAT for NCX1, we 
will have a set of recognition rules for this particular enzyme that can be 
tested with other substrates. There are 22 other DHHC-PATs in the human 
genome and likely many more recognition rules to discover. 
 
Figure Legend 
An amphipathic -helix directs palmitoylation of NCX1. Palmitoylation of 
NCX1 at C739 requires an -helix at the C terminal end of the NCX1 
regulatory intracellular loop. The hydrophobic face of the helix probably 
interacts with the membrane, while the cytosolic hydrophilic face is likely 
recognised by the cellular palmitoylation machinery. 
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